Erythromycin

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Erythromycin
Generic name: ERYTHROMYCIN
Manufacturer: Bausch & Lomb Incorporated
Product type: HUMAN PRESCRIPTION DRUG
SPL set ID: 061ddd20-94a6-4e3c-ba84-1ebd8529eea6
SPL ID: 5a22c8b5-981c-5eb3-e063-6394a90a79f8
Version: 12
Effective date: 2026-08-28
Source export date: 2026-09-28
Source partition: 10
Source file: https://download.open.fda.gov/drug/label/drug-label-0010-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/4bbc9760f647649b787710953d978bd6419e899ba8b90f32c3d972aae43947f8/drug-label-0010-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 06:07:54

Harmonized routes table
Harmonized routes
OPHTHALMIC

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 14 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application applno	ANDA	064067	derived:openfda.application_number
application number		ANDA064067	openfda.application_number
brand name		Erythromycin	openfda.brand_name
generic name		ERYTHROMYCIN	openfda.generic_name
manufacturer name		Bausch & Lomb Incorporated	openfda.manufacturer_name
ndc	package	24208-910-55	openfda.package_ndc
ndc	package	24208-910-19	openfda.package_ndc
ndc	product	24208-910	openfda.product_ndc
ndc11	package	24208091019	derived:openfda.package_ndc
ndc11	package	24208091055	derived:openfda.package_ndc
rxcui		310149	openfda.rxcui
spl id		5a22c8b5-981c-5eb3-e063-6394a90a79f8	id
spl set id		061ddd20-94a6-4e3c-ba84-1ebd8529eea6	set_id
unii		63937KV33D	openfda.unii

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 1 of 1 · 1 matching rows.

adverse reactions

ADVERSE REACTIONS The most frequently reported adverse reactions are minor ocular irritations, redness, and hypersensitivity reactions. To report SUSPECTED ADVERSE REACTIONS, contact Bausch & Lomb Incorporated at 1-800-553-5340 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.